GTY-20967-08978
4 vaccinations
2 coded responses
25 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 601 / IL
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
35P-21149-13388
Child or adolescent in my care · Female · 2022-06-30
HSZ-13674-72820
Child or adolescent in my care · Male · 2022-09-09
Timeline
-
2020-12-17
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-01-21
Dose 2 — Pfizer-BioNTech
-
2021-10-14
Dose 3 — Pfizer-BioNTech
- 2021-10-14
- 2021-10-15
- 2021-10-16
- 2021-10-17
-
2021-10-18
Survey response — days 1–6 daily, dose 3MedDRA: Bursitis — Feeling: Good · Joint painsFree text: Diagnosed with olecranon bursitis on 10/18. Unclear etiology. Started on antibioticsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-20
Survey response — days 1–6 daily, dose 3MedDRA: Bursitis, Nausea, Office visit, Vomiting — Feeling: Poor · Nausea, Vomiting, Diarrhea · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Systemic reaction (other): Started on antibiotics for olecranon bursitis on 10/17. Switched to new antibiotic on 10/19. Developed severe nausea and vomiting after starting new antibiotic · Healthcare visit (other): Went to obstetrics triage unit and received antiemetics and IV fluidsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-20
Report sent to call center — days 1–6 daily, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2021-10-22
-
2021-10-22
Call successfulCompleted over the phone
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2021-11-20
- 2022-01-15
-
2022-09-19
Dose 4 — Moderna
-
2022-09-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Joint pains, Muscle or body achesAdult check-in
-
2022-09-21
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2022-09-22
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-11-02
- 2022-12-19
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | No |
| 2 | 2021-01-21 | Pfizer-BioNTech | No |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
| 4 | 2022-09-19 | Moderna | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Diagnosed with olecranon bursitis on 10/18. Unclear etiology. Started on antibiotics
Systemic reaction (other): Started on antibiotics for olecranon bursitis on 10/17. Switched to new antibiotic on 10/19. Developed severe nausea and vomiting after starting new antibiotic
Healthcare visit (other): Went to obstetrics triage unit and received antiemetics and IV fluids
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SRO | Bursitis | · | · | ✓ |
| SRO | Nausea | · | · | ✓ |
| SRO | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release